“Don’t let migraine call the shots” says actress, Lisa Faulkner, as she teams up with Novartis UK to launch Tame Your Migraine™
Sep 02, 2019
61% of people surveyed living with migraine felt that migraine attacks dictate their life1
60% of people surveyed living with migraine said they had given up hope on finding relief from their condition2
Tame Your Migraine™ equips people with tools they can use to evaluate the impact that migraine is having on their life, and take action
Frimley, September 02, 2019 – To mark Migraine Awareness Week 2019 (01 – 07 September), Novartis UK has joined forces with actress, author and cookery presenter, Lisa Faulkner, to launch Tame Your Migraine™ - a new digital campaign that equips people living with migraine with tools they can use to take back some of the control that migraine steals.
Research conducted by Novartis shows that 62% of people surveyed living with migraine often felt hopeless or helpless due to migraine1, whilst recent research showed that 92% of people surveyed living with migraine said their outlook on life would change if they were less fearful of their condition2.
One of the reasons why migraine can be so difficult to understand and explain to others is that it is unique to each individual. Choosing when to turn up and how much damage to cause, migraine can intrude on family time, spoil plans and hinder career opportunities. Many people who experience the debilitating effects of migraine simply want a cure, so it can be difficult to hear that there is currently no cure. However, there are a range of preventative treatment options that could help reduce the impact of migraine.
Tame Your Migraine is about containing the relentless fear of migraine – from the agony of previous attacks to the anxiety of the next. A message of empowerment and online resource designed to inspire people living with frequent migraine to believe that it is possible to take back some of the control that their migraine currently holds.
“When Novartis approached me about this campaign my overwhelming feeling was one of relief. As someone that endures at least two migraines a month, with each lasting for a few days, I often find it frustrating that there isn’t more recognition and understanding around the impact that this disabling condition can have”, said Lisa Faulkner, actress, author, cookery presenter and Tame Your Migraine campaign ambassador. “Until now, migraine has called the shots. But we want to inspire people to ask for more from their care. If I can help one person have another conversation with their doctor about the options available to them, this campaign will have been a success.”
Dr Giorgio Lambru, Consultant Neurologist and Headache Specialist at Guy’s and St Thomas’ NHS Foundation Trust, London, UK, said: “Some people will have their migraine managed by a GP. Those who experience severe, frequent migraines that are not being effectively controlled may benefit from seeing a doctor who specialises in neurological disorders, including headache. It is important for people living with migraine to aim for the most appropriate treatments tailored to their condition and to ensure that their level of care is proportionate to the level of disability caused by their migraine.”
Haseeb Ahmad, Managing Director UK, Ireland and Nordics, Novartis Pharmaceuticals & Country President UK, said: “We consulted with a number of people living with chronic migraine as part of the development of this campaign. They told us that their lives are dictated by migraine and that they’ve simply had enough. That’s why Tame Your Migraine has a singular purpose – to equip people living with migraine with tools they can use to take back some of the control that migraine steals. By developing a user-friendly resource that enables people to assess, and communicate, the true impact that migraine is having on their life, we hope it helps people to have more effective conversations with their doctor.”
Digital and print Tame Your Migraine advertising will roll out nationally from today, directing people living with migraine towards the campaign website. www.tameyourmigraine.co.uk houses a proprietary migraine assessment tool, which asks the user a series of short questions, to produce a personalised migraine impact report and appointment checklist that can be downloaded. This report is intended to provide a detailed overview of the impact that migraine is having on an individual’s life at any given time, to help guide conversations with a healthcare professional. The Tame Your Migraine website also includes a series of frequently asked questions and list of helpful resources.
About Tame Your Migraine
Tame Your Migraine is a disease awareness campaign, created by Novartis Pharmaceuticals UK Limited alongside, and for, people living with migraine in the UK.
Migraine is a common and disabling neurological condition that causes a wide variety of painful and debilitating symptoms, including but not limited to severe headache3. Latest research shows that around 10 million people in the UK (aged 15-69) experience migraine4, with estimates showing there are over 190,000 migraine attacks every day5. Migraine is more prevalent than diabetes, epilepsy and asthma combined5 and classified as the highest cause of years lived with disability amongst those aged 15-494. Despite this, migraine remains undiagnosed and undertreated in at least 50% of patients6. An estimated £9.7 billion a year is lost in the UK alone due to migraine through direct and indirect costs: in treating patients and in lost productivity4.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
In the UK, we employ approximately 1,500 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is a leading sponsor of clinical trials, in the UK. For more information, please visit www.novartis.co.uk